← All compounds
nootropic0 listings
BPAP
BPAP (R-(-)-1-(Benzofuran-2-yl)-2-propylaminopentane)
Catecholaminergic activity enhancer. Neuro research.
Neuroprotection researchMood research
/ research index
The research base
Research Maturity
★★★☆☆
3/5 — Volume of studies
Evidence Strength
★★★☆☆
3/5 — Quality of evidence
Researched for neuroprotection research.
/ mechanism of action
How it works
Selegiline-related catecholaminergic activity enhancer (CAE); amplifies monoamine release.
/ research dosing
Common research protocols
Range
Research-stage (low dose)
Frequency
Daily, oral
Route
Oral
Cycle
Research courses
Research notes
A potent CAE related to the work on selegiline/PPAP. Active at low doses.
References
FOR RESEARCH USE ONLY. Doses listed are compiled from published research literature, FDA-approved drug labels, and well-documented research community practice. Not medical advice.
/ standalone use
As a solo compound
Standalone oral research compound.
/ side effects
What to know
Generally well-tolerated; see research notes.
/ timeline
Realistic expectations
Weeks
FOR RESEARCH USE ONLY. BPAP is intended for laboratory research and not for human consumption.